Randomized phase II study of CPT-11 versus TXL versus each combination chemotherapy with TS-1 against progressed/relapsed gastric cancer after TS-1 or TS-1/ platinum compounds chemotherapy.

Trial Profile

Randomized phase II study of CPT-11 versus TXL versus each combination chemotherapy with TS-1 against progressed/relapsed gastric cancer after TS-1 or TS-1/ platinum compounds chemotherapy.

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Jan 2015

At a glance

  • Drugs Irinotecan (Primary) ; Gimeracil/oteracil/tegafur; Paclitaxel
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Apr 2013 Actual initiation date changed from May 2007 to 24 Jul 2007 as reported by University Hospital Medical Information Network - Japan.
    • 26 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 20 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top